Selank

Description

Selank is a synthetic analogue of the endogenous immunomodulatory peptide tuftsin, developed alongside Semax as part of the same Russian nootropic-peptide research program. Where Semax research centres on BDNF and cognition, Selank’s research profile leans more toward anxiolytic and immune-modulatory signalling — a distinct but complementary line of investigation from the same peptide family.

Because Selank and Semax are frequently studied together as comparative nootropic peptides, researchers often request both to characterise how closely related short-peptide sequences can diverge in downstream neurological versus immune activity.

Research use only. Store refrigerated and protected from light; typically studied via intranasal or in-vitro protocols per standard peptide handling.